Skip to main content
Fig. 5 | Biomarker Research

Fig. 5

From: A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data

Fig. 5

Decision curve analysis for each model in the training (a) and validation (b) dataset. The y-axis measures the net benefit. Across the threshold probability, the application of radiomics nomogram to predict cirrhosis status provides more benefit than treating all or none of the patients, CT-reported cirrhosis status alone, APRI and FIB-4. APRI, aspartate transaminase-to-platelet ratio index; FIB-4, fibrosis-4

Back to article page